Navigation Links
XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
Date:11/17/2011

f blepharospasm, in 21 countries for the treatment of cervical dystonia (spasmodic torticollis), and in 17 countries for post-stroke spasticity of the upper limb (XEOMIN® is not approved for the treatment of spasticity in the U.S.). Due to unit differences in the LD50 assay, XEOMIN® units are specific to XEOMIN®. Therefore unit doses recommended for XEOMIN® are not interchangeable with those for other preparations of Botulinum toxin. Comparative clinical study results suggest that XEOMIN® and the comparator product containing conventional Botulinum toxin type A complex (900 kD) are of equal potency when used with a dosing conversion ratio of 1:1.

XEOMIN® is the only botulinum toxin product that does not require refrigeration during transport or storage.

XEOMIN® is available in 50 and 100 unit vials. The 50 unit vial helps facilitate flexible dosing and offers reduced product wastage as well as cost savings.

Merz Pharmaceuticals GmbH (www.merz.com):

Merz Pharmaceuticals, a member of the Merz Pharma Group of companies, is an innovative and international specialty healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. In addition to developing XEOMIN®, the company has developed memantine (Namenda®, Memary®, Axura®, Ebixa®) - the first drug for the treatment of moderate to severe Alzheimer's disease, which is marketed by Forest in the US, Daiichi-Sankyo in Japan, and Merz/Lundbeck in Europe and rest of the world. The company also focuses on the development of innovative therapies within the therapeutic areas of hepatology, metabolic diseases and dermatology.

XEOMIN® is a registered trademark of Merz Pharma GmbH & Co KGaA.


'/>"/>
SOURCE Merz Pharmaceuticals GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
2. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
3. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
6. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
7. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
8. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
9. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
10. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
11. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... nation,s top rehabilitation hospitals for spinal cord injury and ... clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... cord injury (SCI). The Phase 1/2a ...
(Date:3/5/2015)... 2015  MGC Diagnostics Corporation (NASDAQ: ... reported financial results for the first quarter ended ... quarter domestic equipment, supplies and accessories revenues increased ... in the 2014 first quarter.  During the quarter, ... in revenue, compared to 14 accounts, or $662,000 ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
(Date:3/5/2015)... 2015 Lakeview Regional Medical Center ... the annual American Heart Association’s Heart Walk as the ... Regional Chief Executive Officer, is serving as Chairman of ... 21, 2015 at Fontainebleau State Park beginning at 9AM. ... 20 individual teams participating in this year’s event. Anyone ...
(Date:3/5/2015)... 2015 New fiber fix heat wrap, a ... a one of a kind product, manufactured to withstand the ... in its short time in the market by customers who ... fiber glass objects which cannot be done with the usual ... really are excited about our new product Fiber Fix Heat ...
(Date:3/5/2015)... TULSA, OK (PRWEB) March 05, 2015 ... been to build a faster, safer, smarter commercial lifting ... the company has an increasing role in more ... lifting systems last month – Octapad System for lifting ... place concrete barriers during road construction projects. , ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 March ... and information campaign sponsored by the Academy of ... into a Healthy Lifestyle," which promotes the consumption ... exercise for achieving and maintaining a healthy weight, ... wellness. , Whether a person is new ...
(Date:3/5/2015)... Medical professionals suggest the physician shortage is ... that is worsening. The demand for doctors far exceeds ... top of the physician shortage, health care organizations and ... with physicians and advanced practitioners throughout the U.S. through ... , Physician openings take an average of 204 days ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Physician Shortage Crisis Worsening 2
... the findings of a UCSF study to be published ... and Gynecology," the risk of miscarriage in pregnant women ... chromosomal abnormalities is lower than previously believed. ,Two ... tests performed during the first and second trimester of ...
... suited to being vegetarians than meat-eaters is among the findings ... 300 leading scientists from New Zealand and overseas. The ... cancer is also under discussion at the conference. ... says the finding that a human is more suited to ...
... US-based Center for Disease Control and Prevention (CDC) ... pharmaceutical development company//, BioDiem, to conduct pre-clinical trials ... its Dutch partner Akzo Nobels Nobilon. ,The ... for research into the prevention and monitoring of ...
... content in cigarettes, thwarting smoking-cessation initiatives. Indeed many steps ... by many nations, inclusion of graphic warnings on cigarettes ... in the cigarettes, on the sly, in a bid ... unique study, the first of its kind undertaken to ...
... Inc.'s (MDT) Activa brain stimulation device, in combination with ... as quality of life in patients with advanced Parkinson's ... ,The study was published in Thursday's issue of the ... the Food and Drug Administration had approved the Activa ...
... of growth of colon polyps to half, it doubles the ... by two significant studies published in the Aug. 31 issue ... Bruce M. Psaty, M.D., Ph.D., and John D. Potter, M.B., ... with it. ,"These two trials provide strong evidence ...
Cached Medicine News:Health News:Prenatal Test and Miscarriage 2Health News:Prenatal Test and Miscarriage 3Health News:Medtronic Device Proves Effective in Parkinson’s Diseas 2Health News:Celebrex- pros and cons 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: